Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Director/PDMR Shareholding

11 Mar 2026 07:00

RNS Number : 1354W
Severfield PLC
11 March 2026
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Due to an administrative oversight, this notification, relating to a transaction on 7 January 2026, is being released at a later date.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul McNerney

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Performance Share Plan as a conditional award of shares. Subject to performance conditions and continued service, the award normally vests in June 2028.

The performance conditions are weighted as follows:

· 50% is based on an EPS target for the year ending 31 March 2028 of 5.8 pence (threshold performance - 12.5% vests) to 7.9 pence (maximum performance - 50% vests) with linear interpolation in between. This represents a PBT range of £22m to £30m.

· 20% is based on an ROCE target for the year ending 31 March 2028 of 10% (threshold performance -5% vests) to 13% (maximum performance - 20% vests) with linear interpolation in between.

· 30% is based on 5 key transformational objectives relating to improved market prioritisation, manufacturing and project delivery. Certain details of the transformation programme metrics are commercially sensitive and will therefore be disclosed retrospectively at the point of vesting.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

1,843,972

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

7/1/26

f)

Place of the transaction

Outside a trading venue

 

 

Name of Company Official responsible for making notification: 

Mark Sanderson, Company Secretary

Contact details: 01845 577896

Severfield plc

Severs House

Dalton Airfield Industrial Estate

Thirsk

North Yorkshire

YO7 3JN

7th January 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJMMTTMTABTMF
Date   Source Headline
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSNotice of FY24 Results Investor Presentation
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in own shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in own shares
2nd May 20244:08 pmRNSBlock listing six monthly return
2nd May 202412:08 pmRNSVoting Rights and Share Capital Update
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:14 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSChairman appointment
17th Apr 20247:00 amRNSTrading Statement
15th Apr 20247:53 amRNSProgressive publish new research
21st Mar 20245:35 pmRNSPDMR Shareholding
19th Feb 20241:58 pmRNSStandard form for notification of major holdings
8th Feb 20247:00 amRNSCDP ‘A List’ for climate change
18th Dec 20231:43 pmRNSDirector/PDMR Shareholding
21st Nov 20238:02 amRNSProgressive publishes new research
21st Nov 20237:00 amRNSInterim Results
6th Nov 20237:00 amRNSNotice of Investor Presentation
9th Oct 20232:46 pmRNSNotification of Transactions of Directors
18th Sep 20234:08 pmRNSRSP grant
6th Sep 20238:54 amRNSProgressive publishes new research
6th Sep 20237:00 amRNSAGM trading update
7th Aug 202312:12 pmRNSNotice of Annual General Meeting and Annual Report
31st Jul 20233:18 pmRNSDirector/PDMR Shareholding
31st Jul 20231:18 pmRNSDirectorate Change
26th Jul 20237:00 amRNSDirectorate Change
14th Jun 20237:00 amRNSNotice of Results and Investor Presentation
14th Jun 20237:00 amRNSFinal Results
18th May 202311:13 amRNSTotal Voting Rights
28th Apr 20237:35 amRNSProgressive publishes Spotlight note
3rd Apr 20232:11 pmRNSCompletion of Acquisition
27th Mar 20237:00 amRNSTrading Statement
21st Mar 202311:03 amRNSNotification of Major Holdings
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.